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Purpose: Skeletal muscle wasting is an independent predictor of health-related quality of life 
and survival in patients with COPD, but the complexity of molecular mechanisms associated 
with this process has not been fully elucidated. We aimed to determine whether an impaired 
ability to repair DNA damage contributes to muscle wasting and the accelerated aging phenotype 
in patients with COPD.
Patients and methods: The levels of phosphorylated H2AX (γH2AX), a molecule that 
promotes DNA repair, were assessed in vastus lateralis biopsies from 10 COPD patients with 
low fat-free mass index (FFMI; COPD
L
), 10 with preserved FFMI and 10 age- and gender-
matched healthy controls. A panel of selected markers for cellular aging processes (CDKN2A/
p16ink4a, SIRT1, SIRT6, and telomere length) were also assessed. Markers of oxidative stress and 
cell damage and a panel of pro-inflammatory and anti-inflammatory cytokines were evaluated. 
Markers of muscle regeneration and apoptosis were also measured.
Results: We observed a decrease in γH2AX expression in COPD
L
, which occurred in associa-
tion with a tendency to increase in CDKN2A/p16ink4a, and a significant decrease in SIRT1 and 
SIRT6 protein levels. Cellular damage and muscle inflammatory markers were also increased 
in COPD
L
.
Conclusion: These data are in keeping with an accelerated aging phenotype as a result of 
impaired DNA repair and dysregulation of cellular homeostasis in the muscle of COPD
L
. These 
data indicate cellular degeneration via stress-induced premature senescence and associated 
inflammatory responses abetted by the senescence-associated secretory phenotype and reflect 
an increased expression of markers of oxidative stress and inflammation.
Keywords: COPD, skeletal muscle wasting, aging, inflammation, apoptosis
Introduction
COPD is associated with several extra-pulmonary effects. Among these, peripheral 
skeletal muscle wasting1 is common and can be present even in those patients with 
normal body weight.2 This has a significant impact on health-related quality of life 
(HRQoL),3 health care utilization,4 morbidity and mortality.5 The molecular mecha-
nisms underlying skeletal muscle wasting are not fully understood and are likely to be 
multifactorial. Several mechanisms have been shown to be linked to muscle wasting 
in COPD, including systemic inflammation,6 oxidative stress,7 cell hypoxia,8 physical 
inactivity9 and nutritional depletion.10
It has recently been reported that the maintenance of peripheral muscle mass 
in COPD may be compromised due to accelerated aging11 and exhaustion of the 
regenerative potential of the muscles.12 In addition, upregulation of genes involved 
in the inhibition of cell growth and cell cycle arrest in COPD patients with 
muscle wasting,13 particularly the expression of CDKN1A/p21WAF1/Cip1 at both the 
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transcript and protein level, has been related to downregu-
lation of histone methyltransferase DOT1L.13,14 Activation 
of CDKN1A/p21WAF1/Cip1 (signaled by the downregulation 
of DOTL1) and the concomitant DNA damage response 
(DDR)15 leads to cell cycle arrest, potentially providing 
time to repair cellular damage through engagement of 
compensatory or repair mechanisms,16 such as DNA repair 
mediated by H2AX.15 It has been shown that CDKN1A/
p21WAF1/Cip1 inactivates H2AX phosphorylation and pro-
motes DNA instability.17 Phosphorylated H2AX (γH2AX) 
promotes assembly of DNA repair complexes at damaged 
sites on chromosomes. In turn, decreased phosphorylation 
of H2AX contributes to the impairment of DNA repair and 
has been linked to cellular senescence and accumulation 
of DNA damage.15
In situations of irreparable damage, CDKN1A/p21WAF1/
Cip1 promotes cellular degeneration by initiating stress-
induced premature senescence triggered by oxidative 
stress,8,18 which is a feature of skeletal muscle in COPD. In 
turn, senescent cells release pro-inflammatory cytokines and 
chemokines as part of the senescence-associated secretory 
phenotype (SASP).19 These alter the tissue microenviron-
ment, attract immune cells and induce, via paracrine medi-
ated changes in nearby cells, a decrease in the replacement 
of damaged cells, as has been reported in aging skeletal 
muscle.20
We hypothesized that cell cycle arrest mediated by 
CDKN1A/p21WAF1/Cip1,13,14 in combination with the downregu-
lation of H2AX, contributes to the impairment of DNA repair, 
promoting cellular degeneration by initiating stress-induced 
premature senescence. This facilitates a SASP that further 
interferes with the replacement of damaged cells in patients 
with COPD and muscle wasting. To test this hypothesis, we 
assessed γH2AX protein levels in the vastus lateralis muscle 
of patients with COPD with and without low fat-free mass 
index (FFMI), as a surrogate of muscle mass wasting, and 
in a group of age- and gender-matched healthy controls. 
Several markers of cellular aging and stress (telomere length, 
CDKN2A/p16ink4a, Sirtuin 1 and Sirtuin 6) were also assessed 
to confirm any cellular senescence phenotype, while markers 
of oxidative stress and cytokine expression were assessed 
to confirm the stress-induced premature senescence and the 
SASP. We also hypothesized that these chains of events 
would further interfere with the replacement of damaged 
cells, potentially leading to programmed cell death in the 
muscle of COPD patients with low FFMI (COPD
L
). Cor-
respondingly, we also assessed the expression of MyoD and 
markers of apoptosis.
Patients and methods
study group and patient’s characteristics
A total of 20 stable patients with COPD, 10 with low FFMI and 
10 with normal FFMI, and 10 age-, gender- and smoking sta-
tus-matched healthy subjects with normal FFMI were included 
in the study (Table 1). All patients had been diagnosed with 
COPD according to the Global Initiative for Chronic Obstruc-
tive Lung Disease.21 Patients were clinically stable and free of 
exacerbations for 4 weeks before inclusion in the study. All 
participants were informed of any risks and discomfort associ-
ated with the study, and written informed consent was obtained. 
The study was approved by the Lothian Regional Ethics Com-
mittee. The following baseline assessments were performed 
for each study participant: anthropometric measurements, 
body composition measured by bioimpedance (TBF-300M; 
Tanita Corporation, Tokyo, Japan), spirometry (Alpha Spirom-
eter; Vitalograph, Buckingham, UK), blood gases (Ciba 
Corning 800; Corning Incorporated, Corning, NY, USA), 
6-minute walking distance, quadriceps maximal voluntary 
contraction (QMVC; Chatillon® K-MSC 500; Ametek, Doral, 
FL, USA), HRQoL questionnaires (St George’s Respiratory 
Questionnaire, SGRQ), modified Medical Research Council 
(mMRC) dyspnea scale and physical activity levels using 
the Voorrips physical activity questionnaire and the Lon-
don Chest Activity of Daily Living Scale for patients with 
COPD. The number of exacerbations in the previous year 
was recorded. Low FFMI was defined as ,16 kg⋅m−2 for male 
COPD patients and ,15 kg⋅m−2 for female COPD patients.22
Muscle biopsy
An open muscle biopsy of the vastus lateralis was collected 
in the Clinical Research Facility using a standard surgical 
technique. Immediately after collection, samples were 
divided into three groups: 1) fixed in formaldehyde and par-
affin embedded, 2) perfused with RNA stabilization reagent 
(RNAlater®; Thermo Fisher Scientific, Waltham, MA, USA) 
and stored at −20°C and 3) immediately frozen in liquid 
nitrogen and stored at −80°C for further analyses.
Vastus lateralis muscle protein extraction
Total protein was extracted and purified from ~0.1 g vastus 
lateralis muscle by homogenization of tissue in radioimmu-
noprecipitation assay buffer using standard procedures. Total 
protein was measured by the bicinchoninic acid method.
Skeletal muscle fiber composition
Paraffin-embedded tissue sections (5 μm) were de-waxed and 
rehydrated through graded ethanol using standard procedures. 
Five images per patient were included in the analysis. A total 
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
12
9.
21
5.
69
.1
44
 o
n 
30
-J
un
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of COPD 2018:13 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1989
role of accelerated aging in limb muscle wasting of patients with COPD
of 959.6±146.4, 715.0±89.2 and 918.6±95.2 fibers in control 
subjects, COPD patients with normal FFMI (COPD
N
) and 
COPD
L
, respectively, were assessed. Type I, type II and 
hybrid fibers were counted using a manual tag protocol using 
Image-Pro® Plus (Media Cybernetics, Inc., Bethesda, MD, 
USA) and expressed as a proportion of total fibers assessed.
Immunoblotting
Twenty micrograms of total protein was used per sample. The 
following primary antibodies were used: γH2AX (1:1,000, 
2577S; Cell Signaling Technology, Inc., Danvers, MA, USA); 
CDKN2A/p16ink4a (1:1,000, ab 81278; Abcam, Cambridge, 
UK); SIRT1 (1:1,000, ab 32441; Abcam); SIRT6 (1:1,000, 
ABE102; EMD Millipore, Billerica, MA, USA); anti-perilipin 
A (1:1,000, P1998-200UL; Sigma-Aldrich Co., St Louis, MO, 
USA); anti-MyoD1 (1:1,000; Abcam); cleaved caspase-3 
(Asp175; 1:1,000, 9661S; Cell Signaling Technology, Inc.). 
GAPDH was used as a load control (1:5,000; Santa Cruz 
Biotechnology Inc., Dallas, TX, USA). The optical densities 
were quantified using a densitometer and Image-Pro Plus.
relative telomere length measurement
DNA was isolated from vastus lateralis biopsies using 
Maxwell®16 machine (Promega Corporation, Fitchburg, WI, 
USA) according to the manufacturers’ instructions. DNA 
concentration and integrity were assessed by NanoDrop 
1000 Spectrophotometer (NanoDrop® ND-1000; NanoDrop, 
Wilmington, DE, USA). Relative telomere length was 
Table 1 Clinical and experimental cohort characteristics
Characteristics Controls Diff COPDN Diff COPDL Diff p-value
Male/female 8/2 a 8/2 a 8/2 a ns
age (years) 68.3±4.4 68.9±4.6 66.7±5.9 ns
height (m) 1.74±0.08 a 1.70±0.09 a 1.67±0.08 a ns
Weight (kg) 89.93±15.63 a 76.1±12.65 a 51.71±5.71 B 0.0001
BMI (kg⋅m−2) 30.6±6.9 a 26.0±2.2 a 18.9±1.9 B ,0.0001
FFM (kg) 62.55±11.35 a 54.13±10.13 a 43±5.69 B ,0.005
FFMI (kg⋅m−2) 20.4±2.7 a 18.6±1.4 a 15.3±0.7 B ,0.0001
active/ex-smokers 2/8 a 2/8 a 2/8 a ns
number of cigarettes (pack-years) 31.9±15.8 a 48.7±21 a 64.3±39.8 a ns
average smoking cessation (years) 23.2±17.3 a 8.4±7 B 5.4±7.4 B ,0.01
age at smoking cessation (years) 45.1±15.5 a 60.5±7.6 B 61.3±7.8 B ,0.01
mMrC  2.9±1.3 4.1±1.1 ns
FeV1 (l) 2.8±0.6 a 1.2±0.5 B 0.9±0.4 B ,0.0001
FeV1 (% predicted) 94.4±12.6 a 44.1±18.3 B 33.2±13.7 B ,0.0001
FVC (l) 3.9±0.7 a 2.7±1.1 B 2.6±1 B ,0.01
FVC (% predicted) 103.7±10.1 a 87.8±28.5 aB 76.5±18.2 B ,0.05
FeV1/FVC 0.7±0 a 0.4±0.1 B 0.3±0.1 B ,0.0001
PaO2 (mmhg) 73.1±5.4 a 70.2±9.8 75.2±13.1 ns
PaCO2 (mmhg) 41.8±1.7 a 41±3.4 43.1±5.2 ns
Physical activity (V) 11.0±4.6 a 7.2±6 B 1.1±1 C ,0.0001
Physical activity (l)  30±15.8 43.5±10.4 ns
QMVC (n) 366.6±84.8 a 323.3±81 a 202.2±51.8 B ,0.005
6MWD (m) 523.8±120.1 a 411±158.4 B 327±134.1 B ,0.01
exacerbation 1.8±1.5 a 4±2.2 B ,0.05
BODe index   4±2.7 a 6.2±2.3 a ns
sgrQ symptoms   60.1±13.4 a 78.3±15.2 B ,0.05
sgrQ activity   52.1±29.2 a 86.2±13.4 B ,0.005
sgrQ impact   33±24.4 a 59.5±20.8 B ,0.05
sgrQ total   43.5±21.7 a 70.7±16.4 B ,0.01
Type I fiber (%) 38.5±11 a 23.9±9.3 B 24.7±13.5 B ,0.05
Type II area (μ2) 2,564±783.8 aB 2,978±785.9 a 2,034±498.8 B ,0.05
Notes: Physical activity (V): Voorrips questionnaire; physical activity (l): london Chest activity of Daily living scale. Comparisons among groups were performed using 
anOVa and student–newman–Keuls as a post hoc test. Diff among the three different groups are stated using letters a, B and C, where sharing a letter implies no 
differences between these groups and having a different letter implies a statistical difference in the post hoc test.
Abbreviations: 6MWD, 6-minute walking distance; ANOVA, analysis of variance; BMI, body mass index; BODE index, Body-mass index, airflow Obstruction, Dyspnea, and 
exercise; COPDl, COPD patients with low FFMI; COPDn, COPD patients with normal FFMI; Diff, differences; FeV1, forced expiratory volume in 1 second; FFM, fat-free 
mass; FFMI, fat-free mass index; FVC, forced vital capacity; mMRC, modified Medical Research Council; ns, not significant; PaCO2, arterial carbon dioxide partial pressure; 
PaO2, arterial oxygen partial pressure; QMVC, quadriceps maximal voluntary contraction; sgrQ, st george’s respiratory Questionnaire.
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measured by quantitative polymerase chain reaction (PCR) 
following the method described by Cawthon et al.23
Muscle oxidative stress markers
4-Hydroxy-2-nonenal (HNE) levels were assessed by incu-
bating the membrane with polyclonal anti-HNE antibody 
(1/3,000, AB5605; EMD Millipore). Specific proteins were 
detected with horseradish peroxidase-conjugated secondary 
antibody and a chemiluminescence kit.
Measurement of muscle inflammatory 
markers
Muscle cytokine levels were measured using Cytometric 
Bead Array (BD Biosciences, San Jose, CA, USA) for simul-
taneous detection of 10 cytokines (TNFα, soluble receptor 
TNFR
I
, soluble receptor TNFR
II
, IFNγ, IL1β, IL5, IL6, IL8, 
IL10 and IL12p70) in tissue homogenate.
Terminal deoxynucleotidyl transferase-
mediated dUTP nick end-labeling 
(TUnel) assay
TUNEL assay was used to evaluate cell apoptosis in paraffin-
embedded sections of vastus lateralis following the manu-
facturer’s instructions. Apoptotic nuclei were expressed as 
the percentage of the TUNEL-positive nuclei (red stain) 
from the total number of counted nuclei (blue). A total 
of 200 nuclei were the minimum amount counted in each 
paraffin-embedded section. Positive and negative controls 
were included for each section.
statistical analyses
Data are expressed as mean ± standard error of the mean (SEM). 
Each variable was tested for normal distribution using the Kol-
mogorov–Smirnov test and statistical test selected accordingly. 
Analysis of variance (ANOVA) with Student–Newman–Keuls 
as a post hoc test was used for normally distributed variables, 
while a Kruskal–Wallis test with Dunn’s post hoc test was 
applied to non-normally distributed variables. Correlation 
analysis was performed using Pearson or Spearman tests for 
normally and non-normally distributed variables, respectively. 
A p-value of ,0.05 was considered statistically significant. 
The data were analyzed using the statistical package pro-
gram SAS version 9.3 (SAS Institute Inc., Cary, NC, USA).
Results
Patient’s characteristics
Anthropometric characteristics and pulmonary function data 
for the study subjects are summarized in Table 1. Both groups 
of COPD patients had airflow limitation compared to healthy 
controls, which had normal spirometry. There were no signifi-
cant differences in spirometry between COPD
N
 and COPD
L
. 
Detailed description of the study subjects with clinical and 
experimental parameters, methods and results is given in 
Supplementary materials.
The subjects with COPD
L
 had lower body mass index 
(BMI), fat-free mass (FFM), FFMI (as expected by the study 
design), poorer HRQoL with higher values in all the domains 
of the SGRQ and worse muscle function as assessed by 
QMVC as compared to COPD
N
. No statistical differences in 
physical activity measured by the Voorrips questionnaire or 
activities of daily living (ADLs) assessed with the London 
Chest Activity of Daily Living were seen between the two 
groups of COPD patients, although there was a trend toward 
lower physical activity measured by London Chest Activity 
of Daily Living in COPD
L
.
Both COPD groups showed a redistribution of muscle 
fiber type with a higher proportion of type II fibers and a 
lower proportion of type I in comparison to healthy controls. 
Type II fiber area was reduced in COPD
L
 in comparison to 
COPD
N
 and controls but only reached statistical significance 
difference with COPD
N
 (Table 1; Figure 1).
High percentage of hybrid fiber type was found in COPD
L
 
in comparison to COPD
N
 and controls (statistically difference 
only vs controls), which suggests that the transformation 
from one fiber type to another could constitute a mechanism 
leading to the redistribution and atrophy of fibers seen in 
COPD.1 Vastus lateralis of patients with COPD and muscle 
wasting exhibit higher levels of lipid infiltration as shown 
by higher levels of perilipin A in comparison to both COPD
N
 
and healthy controls (Figure S1).
Dna repair and biomarkers of aging
γH2AX levels were reduced in COPD
N
 in comparison to 
controls and further reduced in COPD
L
 patients, but only 
the latter reached statistical significance (Figure 2). Both 
COPD groups displayed an increase in CDKN2A/p16ink4a 
levels, although statistical significance was not reached when 
compared to controls (Figure 3A). Furthermore, SIRT1 levels 
were decreased in COPD
L
 in comparison to COPD
N
 and 
controls (Figure 3B) but only reached statistical significance 
against controls. In turn, reduced levels of SIRT6 were seen in 
COPD
L
 in comparison to both COPD
N
 and controls (p,0.05) 
(Figure 3C). No significant differences in the relative telomere 
length between analyzed groups were noted (Figure 4).
Oxidative stress in COPD
The anti-HNE antibody detected five positive protein bands 
with apparent mass ranging from 30 to 150 kDa. The intensities 
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of all the HNE-positive bands and total HNE optical densities 
were greater in muscles of COPD
L
 compared to COPD
N
 and 
control subjects. However, only one band (band 3) reached 
statistical significance against COPD
N
 (p,0.05; Figure 5).
Markers of inflammation in vastus lateralis
Figure 6 shows cytokine expressions in all three groups. 
COPD
L
 patients showed higher levels of TNFR
II
, IL8, IL1β 
and IL10 in comparison to COPD
N
 and controls but reached 
statistical significance only against controls.
TNFα was increased in both COPD groups in com-
parison to controls but only COPD
L
 reached statistical 
significance.
A strong tendency toward increased levels of TNFR
I
 
(p=0.1), IFNγ (p=0.052) and IL12p70 (p=0.09) was noted in 
COPD patients compared to healthy controls, most notably in 
the COPD
L
 group. IL12p70 was also increased in both COPD 
groups in comparison to controls but this did not reach statisti-
cal significance. IL5 was statistically significantly increased 
in both COPD groups in comparison to healthy controls.
Figure 1 Vastus lateralis fiber characteristics.
Notes: Mean (SEM) values for the percentage of type I fibers (A), the percentage of type II fibers (B), the percentage of hybrid fibers (C) and type II fiber size (area) (D) in 
healthy controls (), COPDn () and COPDl (). Data are presented as mean ± seM. *p,0.05.
Abbreviations: COPDl, COPD patients with low FFMI; COPDn, COPD patients with normal FFMI; FFMI, fat-free mass index; seM, standard error of the mean.
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Several cytokines were correlated with lung function 
parameters, exercise tolerance and muscle function and 
structure (Table 2).
Muscle regeneration and apoptosis
An increase in MyoD protein content was observed in 
patients with COPD
L
 in comparison to COPD
N
 and healthy 
controls and only reached statistical significance against 
controls (p,0.05; Figure 7). Equally, COPD
L
 showed signifi-
cantly higher levels of the cleaved caspase-3 in comparison to 
healthy controls (p,0.05; Figure 8A). TUNEL assays showed 
that the percentage of apoptotic nuclei was higher in COPD
L
 
(55.7±25.48) in comparison to COPD
N
 (51.6±25.49) and 
healthy controls (37.5±37.51) but this difference did not reach 
statistical significance (p=0.42; Figure 8B and C).
Discussion
Our data are consistent with a decreased ability to repair 
DNA in the vastus lateralis of patients with COPD and muscle 
wasting. Increased markers of oxidative stress reflected 
a stress-induced premature senescence in keeping with 
our previous findings of increased CDKN1A/p21WAF1/Cip113 
mediated by downregulation of DOT1L.14 Furthermore, 
reduced levels of Sirtuin 1 and Sirtuin 6, are consistent 
with this hypothesis. This leads to a SASP reflected by the 
increased levels of vastus lateralis cytokine expression. 
In turn, COPD
L
 muscle showed evidence of structural 
and functional impairment, such as type II fiber atrophy, 
Figure 4 relative telomere length in vastus lateralis muscle of COPDl, COPDn, 
and healthy controls.
Notes: Data are presented as mean ± seM. relative T/s ratio: repeat copy number 
to single copy gene number.
Abbreviations: COPDl, COPD patients with low FFMI; COPDn, COPD patients 
with normal FFMI; FFMI, fat-free mass index; seM, standard error of the mean.
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increased proportion of type II fibers, lipid infiltration 
(perilipin A) and reduced QMVC.
DNA damage triggers a response that aims to restore 
DNA integrity through repair. This DDR is initiated via the 
recognition of the damage by a number of protein kinases, 
where phosphorylation of H2AX promotes assembly of 
DNA repair complexes at damaged sites of chromosomes 
and phosphorylation of Chk1 and Chk2 kinases. The latter 
induces temporal cell cycle arrest via the p53/CDKN1A/
p21WAF1/Cip1 and CDC25/cdk1 pathways. An increased acti-
vation of p53–CDKN1A/p21WAF1/Cip1 signaling, due to the 
persistent damage, would lead to an increased number of 
γH2AX foci and a permanent growth arrest or apoptosis. 
We have previously shown the upregulation of CDKN1A/
p21WAF1/Cip113 concomitant with the downregulation of DOT1L 
in the same study population. In the current investigation, 
we have shown significantly lower levels of γH2AX only in 
COPD patients with muscle wasting in comparison to healthy 
controls. It is known that the downregulation of H2AX leads 
to a greater accumulation of CDKN1A/p21WAF1/Cip1, whereas 
the overexpression of CDKN1A/p21WAF1/Cip1 inactivates 
H2AX phosphorylation and promotes DNA instability.17 
Figure 5 assessment of lipid peroxidation; protein levels of hne (bands 1–5, molecular weight ranging from 30 to 150 kDa) in vastus lateralis muscle of COPDl, COPDn, 
and healthy controls.
Note: Data are presented as mean ± seM, *p,0.05.
Abbreviations: COPDl, COPD patients with low FFMI; COPDn, COPD patients with normal FFMI; FFMI, fat-free mass index; hne, 4-hydroxy-2-nonenal; seM, standard 
error of the mean.
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Our findings are consistent with previous studies which 
demonstrate that decreased levels of γH2AX focus formation 
were associated with increased DNA damage.17 Age-related 
deterioration of DDR can explain, at least in part, the inability 
of senescent cells to phosphorylate H2AX and form foci.17
To further investigate this hypothesis, we have assessed 
levels of proven markers of cellular stress and senescence, 
namely SIRT1 and SIRT6.24
Sirtuins are a family of nicotinamide adenine dinucleotide+-
dependent protein deacetylases involved in stress resistance 
and metabolic homeostasis.24 SIRT1 possesses multiple 
metabolic functions including the increase in cellular stress 
resistance and the suppression of apoptosis, which might 
indicate a beneficial role in longevity.25 SIRT6 is reported to 
influence genomic instability playing a role in DNA repair by 
modulating metabolic processes to minimize reactive oxygen 
species (ROS) production and DNA damage.25
We found a decrease in SIRT1 and SIRT6 protein levels 
in the COPD
L
 group.
Decrease in SIRT1 and SIRT6 expression together 
with increased CDKN2A/p16ink4a expression (although not 
statistically significant) suggests the dysregulation of cellular 
homeostasis, activation of cellular damage responses and 
accelerated physiological senescence.
Figure 6 (Continued)
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role of accelerated aging in limb muscle wasting of patients with COPD
Table 2 Correlations between muscle cytokine levels and clinical 
parameters
IL5 IL8 IL1β IL10 TNFα TNFRI TNFRII
FeV1
r −0.49 −0.52 −0.50 −0.40 −0.51 −0.57
p-value ,0.01 ,0.005 ,0.005 ,0.05 ,0.005 ,0.001
QMVC
r −0.41 −0.48 −0.46 −0.39 −0.55 −0.41 −0.54
p-value ,0.05 ,0.05 ,0.01 ,0.05 ,0.005 ,0.05 ,0.005
6MWD
r −0.46 −0.59 −0.40 −0.58 −0.42 −0.53
p-value ,0.05 ,0.005 ,0.05 ,0.005 ,0.05 ,0.005
Note: Correlations (r- and p-values) between vastus lateralis cytokines and 
parameters of lung function, exercise tolerance and muscle function.
Abbreviations: 6MWD, 6-minute walking distance; FeV1, forced expiratory volume 
in 1 second; QMVC, quadriceps maximal voluntary contraction.
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Figure 7 MyoD protein levels in vastus lateralis muscle of COPDl (), COPDn () 
and healthy controls ().
Notes: Data are presented as mean ± seM; *p,0.05. 
Abbreviations: COPDl, COPD patients with low FFMI; COPDn, COPD patients 
with normal FFMI; FFMI, fat-free mass index; seM, standard error of the mean.
SIRT1 is a negative regulator of p53-induced damage 
responses.26 It has been reported that a lack of SIRT1 associ-
ates with a reduced ability to repair DNA damage.27 SIRT1 
is markedly reduced in peripheral blood and lung tissue from 
patients with COPD as a result of excessive oxidative stress.28 
SIRT6 is an important modulator of DNA repair26 and is 
also reduced in COPD lungs.29 Interestingly, SIRT6 action 
is complex and may reflect changes in metabolic status 
of cells.25 Low levels of SIRT1 and SIRT6 indicate more 
evidence of DNA damage confirmed by the downregulation 
of γH2AX and high levels of CDKN1A/p21WAF1/Cip1.
It is of note that, although COPD
L
 showed the lowest 
levels of SIRT1 and SIRT6 and this was statistically sig-
nificant in comparison to the control group, there was no 
statistically significant difference with COPD
N
. However, 
there was also no difference in these markers of aging 
Figure 6 Vastus lateralis cytokine profiling in COPDl, COPDn and healthy controls.
Notes: Data are presented as mean ± seM; *p,0.05, **p,0.01.
Abbreviations: COPDl, COPD patients with low FFMI; COPDn, COPD patients with normal FFMI; FFMI, fat-free mass index; prot, protein; seM, standard error of the mean.
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between COPD
N
 and controls. Despite this lack of statistical 
difference between COPD
L
 and COPD
N
, there was a clear 
difference in FFMI, function (QMVC) and structure (type II 
atrophy, perilipin A expression) in the COPD
L
 in comparison 
to COPD
N
. It can be hypothesized that these markers were 
not reduced enough below a “threshold” to initiate the aging 
process in the COPD
N
 population, although this remained 
to be elucidated. The fact that CDKN1A/p21WAF1/Cip1 was 
increased only on the COPD
L
 in the same population in our 
previous publication is in keeping with this. It is also possible 
that the reduced sample size precludes these differences to 
reach statistical significance as given in the “Limitations of 
the study” section.
The relative contribution of the p53/CDKN1A/p21WAF1/Cip1 
and CDKN2A/p16ink4a effector pathways to the initial growth 
arrest can vary depending on the type of the stress.16 DNA dam-
age initially halts cell cycle progression through the induction 
of CDKN1A/p21WAF1/Cip1, but if lesions persist, this activates 
CDKN2A/p16ink4a through p38-MAPK-mediated mitochon-
drial dysfunction and ROS production.30 We have previously 
demonstrated an upregulation of CDKN1A/p21WAF1/Cip1 in the 
subgroup of patients with muscle wasting.
The absence of changes in telomere length suggests 
that muscle cells are undergoing a stress-induced prema-
ture senescence rather than replicative senescence. It has 
been reported that stress induced premature senescence is 
independent of telomere attrition in keeping with the cur-
rent findings. Moreover, several other stresses have been 
shown to induce a senescent growth arrest in vitro, including 
certain DNA lesions and ROS.31 In line with this, our data 
showed higher levels of oxidative stress markers (HNE). 
Interestingly, we have previously found the upregulation 
of heat shock protein beta-1 and alpha-crystallin B chain 
involved in oxidative stress protection in COPD
L
.14 Evidence 
of oxidative stress has previously been shown in peripheral 
muscle of COPD patients18,32 especially in patients with low 
BMI33 and hypoxemia.8 This suggests that oxidative stress 
may play a role as a trigger of stress-induced senescence in 
COPD patients with muscle wasting who display a reduced 
ability to protect against oxidative stress.34,35
Irrespective of the senescence-inducing stressor or 
mechanism,19 senescent cells express a SASP. Pro-inflam-
matory cytokines and chemokines are among the SASP 
components that are highly conserved across cell types and 
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Figure 8 (A) Protein levels of cleaved caspase-3 in vastus lateralis muscle of COPDl (), COPDn () and healthy controls (). (B) Confocal microscope images of TUnel 
assay in paraffin-embedded sections of vastus lateralis muscle, blue stain (DAPI) normal nuclei; red stain (TUNEL stain); double stain (red + blue) apoptotic nuclei. (C) TUnel 
assay. Data are presented as mean ± seM; *p,0.05 COPDl patients compared to healthy controls. 
Abbreviations: COPDl, COPD patients with low FFMI; COPDn, COPD patients with normal FFMI; DaPI, 4′,6-diamidino-2-phenylindole; FFMI, fat-free mass index; seM, 
standard error of the mean; TUnel, transferase-mediated dUTP nick end-labeling.
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role of accelerated aging in limb muscle wasting of patients with COPD
senescence-inducing stimuli, which suggest that attracting 
immune cells and inducing local inflammation are common 
properties of senescent cells. To further investigate the local 
release of cytokines, a panel of anti- and pro-inflammatory 
cytokines was assessed in the vastus lateralis of our popula-
tion. The levels of the inflammatory markers were higher in 
the vastus lateralis of patients with COPD, particularly in 
the COPD
L
 group.36 It is difficult to establish the relevance 
of the changes between the groups. Interestingly, when the 
relationship between cytokine levels and relevant clinical 
outcomes was explored (ie, forced expiratory volume in 
1 second [FEV
1
], QMVC, 6-minute walk test [6MWT]), there 
were significant correlations between these clinical outcomes 
and levels of cytokines in the muscle (Table 2).
It has been reported that severe stress induces apoptosis, 
whereas mild damage induces accelerated aging.37 However, 
increasing evidence has shown that the outcome of cell stress is 
not entirely dose dependent38 and that the responses of cells seem 
to be predetermined by their tissue of origin. Previous studies 
have shown increased markers of apoptosis in skeletal muscle of 
patients with COPD39 together with an increased mitochondrial 
cytochrome C release in response to stress.40 Our data showed 
higher levels of programmed cell death in the muscle of COPD 
patients. This suggests that cellular senescence and apopto-
sis are not mutually exclusive and can coexist in the muscle.
Our results are in keeping with previous studies showing 
that limb muscles of patients with COPD have increased 
number of senescent satellite cells and an exhausted muscle 
regenerative capacity, compromising the maintenance of 
muscle mass in these individuals.11 The higher expression 
of MyoD, the muscle-specific transcription factor associated 
with muscle differentiation seen in COPD
L
, may reflect an 
unsuccessful attempt to maintain muscle mass, which could 
be mediated by the downregulation of SIRT1.41
limitations of the study
In this study, only the γH2AX has been measured. The ratio 
γH2AX/H2AX has, therefore, not been calculated. Although 
this would have added information on the relationship 
between the phosphorylated and non-phosphorylated form, 
it is the phosphorylation of histone H2AX that is implicated 
in the maintenance of DNA stability, and its levels strongly 
increase following DNA damage.17
Moreover, it is expected to find higher levels of γH2AX 
in cells exposed to genotoxic stresses as occurred in our 
population of COPD patients with muscle wasting. We believe 
that limiting our study to the γH2AX would not affect the 
validity of the findings.
Another limitation of the study is the small sample size. 
Studies requiring invasive techniques such as a muscle biopsy 
are difficult to recruit. This may have influenced the lack of 
statistical difference in some of the assessments (ie, SIRT1 
and SIRT6). Although a clear tendency was seen in the levels 
of these molecules, only statistical differences were reached 
between COPD
L
 and controls. We believe that this could be 
due to a type II error. A sample size of 22 patients per group 
would have been necessary to reach statistical differences 
with a power of 90% (ie, for SIRT1).
Conclusion
This study demonstrates an impaired capacity for DNA repair 
and the differential expression of proteins related to cell cycle 
arrest and accelerated aging showing the evidence of cellular 
senescence in vastus lateralis of COPD patients with muscle 
wasting. High levels of oxidative stress suggest that this 
mechanism may be the trigger for stress-induced premature 
senescence in the muscle of COPD patients. High levels of 
inflammatory markers suggest the evidence of an SASP. Pre-
mature cellular senescence and subsequent exhaustion of the 
muscle regenerative potential may thus be related to the muscle 
abnormalities that are characteristics of these patients.
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